Reducing reductionism: addressing risk for atherosclerotic cardiovascular disease by apolipoprotein proteomics

被引：0
|
作者：
Schmidt, Lukas E. [1 ]
Speidl, Walter S. [1 ]
Tsimikas, Sotirios [2 ]
Mayr, Manuel [1 ,3 ]
机构：
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Univ Calif San Diego, Sulpizio Cardiovasc Ctr, Div Cardiovasc Med, La Jolla, CA USA
[3] Kings Coll London, Kings British Heart Fdn Ctr, Sch Cardiovasc & Metab Med & Sci, 125 Coldharbour Lane, London SE5 9NU, Greater London, England
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 27期
关键词：
D O I：
10.1093/eurheartj/ehad294
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2420 / 2422
页数：3
相关论文
共 50 条
  • [1] Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
    Nurmohamed, Nick S.
    Kraaijenhof, Jordan M.
    Mayr, Manuel
    Nicholls, Stephen J.
    Koenig, Wolfgang
    Catapano, Alberico L.
    Stroes, Erik S. G.
    [J]. EUROPEAN HEART JOURNAL, 2023, : 1594 - 1607
  • [2] Addressing atherosclerotic cardiovascular disease risk in persons with HIV
    Masenga, Sepiso K.
    Woolley, Ian J.
    [J]. AIDS, 2023, 37 (14) : 2251 - 2252
  • [3] Addressing atherosclerotic cardiovascular disease risk in South Asians: A daunting task ahead
    Gupta, Milan
    [J]. ATHEROSCLEROSIS, 2020, 315 : 76 - 78
  • [4] Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine
    Patel, Kershaw V.
    Pandey, Ambarish
    de Lemos, James A.
    [J]. CIRCULATION, 2018, 137 (24) : 2551 - 2553
  • [5] Reducing the risk of atherosclerotic cardiovascular disease in people with hemophilia: the importance of primary prevention
    Dix, Caroline
    Dolan, Gerry
    Hunt, Beverley J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (05) : 1304 - 1312
  • [6] Apolipoprotein B: its advantages in the assessment of atherosclerotic cardiovascular risk
    Coniglio, Raul Ignacio
    [J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2021, 55 (01): : 11 - 20
  • [7] Apolipoprotein B: An essential cholesterol metric for atherosclerotic cardiovascular disease
    Fischer, Kyle
    Kassem, Layla
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (02) : 83 - 86
  • [8] Reducing risk for cardiovascular disease
    Foreyt, JP
    Poston, WSC
    [J]. PSYCHOTHERAPY, 1996, 33 (04) : 576 - 586
  • [9] Periodontal disease, a risk factor for atherosclerotic cardiovascular disease
    Gheorghita Dorottya
    Eordegh Gabriella
    Nagy Ferenc
    Antal Mark
    [J]. ORVOSI HETILAP, 2019, 160 (11) : 419 - 425
  • [10] Apolipoprotein E genotype, lipoprotein (a) and atherosclerotic cardiovascular disease in CAPD patients
    Lee, JS
    Ryu, JS
    Kweon, TW
    Yang, WS
    Kim, SB
    Min, WK
    Park, JS
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1028 - A1028
12345